Papers and Presentations
How to Search for Resources
You can search for a variety of content on the CASSS website. CASSS makes available any content with author approval. Narrow your search by using the various filters shown below, such as Resource Type, Event Type, and Year. Refine your search as needed.
Refine Results
Filter By Resource Type
Filter By Event Types
- WCBP (461)
- Cell & Gene Therapy Products (230)
- CMC Strategy Forum Europe (196)
- CE Pharm (187)
- Mass Spectrometry (173)
- Bioassays (134)
- Higher Order Structure (109)
- AT Europe (109)
- CMC Strategy Forum Japan (105)
- CMC Strategy Forum (78)
- CMC Strategy Forum North America Winter (77)
- CMC Strategy Forum North America Summer (61)
- CMC Strategy Forum Latin America (40)
- CGTP Summit (37)
- CMC Strategy Forum China (29)
- Consultants' Network (15)
- CMC Strategy Forum North America Fall (14)
- CGTP Europe (11)
- Symposium on mRNA (11)
- Virtual Summit: Bioconjugates (9)
- Virtual Summit: Manufacturing (8)
- Biophysics Working Group (8)
- Virtual Europe Discussion Group (8)
- CGTP Virtual Summit (7)
- NorCal Regional Forum (6)
- Netherlands Area Biotech Discussion Group (5)
- DC Area Scientific Discussion Group (4)
- Biotech Working Group (2)
- Midwest Regional Forum (2)
- CMC-Vaccines Working Group (1)
Filter By Tags
-
Differences and Similarities Between Antibody Drug Conjugates (ADCs) & Antibody Oligonucleotide Conjugates (AOCs)
Speaker Presentation: CMC Strategy Forum Europe 2026 Lingaraju Gondichatnahalli Manjappa, Novartis Pharma … -
Achieving Positive Change to the Global CMC Regulatory Environment
Speaker Presentation: CMC Strategy Forum Europe 2026 Lennard Andrew, Amgen Limited, 2026 -
From LAL to Recombinant Methods - Regulatory Expectations and Challenges in the EU
Speaker Presentation: CMC Strategy Forum Europe 2026 Ladinová Barbora, SÚKL, 2026 -
Stability Modelling for Biotherapeutics – a Company Perspective and Case Studies
Speaker Presentation: CMC Strategy Forum Europe 2026 Kuzman Drago, Piuzzi Salome, Novartis Pharma … -
Regulatory Strategy to Enable Enterprise-Wide Replacement of LAL With Recombinant Cascade Reagent (rCR) Technology
Speaker Presentation: CMC Strategy Forum Europe 2026 Jacobs Amanda, AstraZeneca, 2026 -
Imaging Using Radioconjugates: Overview, Global Quality Guidance and Regulatory Pathways
Speaker Presentation: CMC Strategy Forum Europe 2026 Jackman Hayley, AstraZeneca, 2026 -
Evolution of Pyrogen and Endotoxin Testing in Plasma‑Derived Medicinal Products (PDMPs) and Vaccines
Speaker Presentation: CMC Strategy Forum Europe 2026 Gysin René, Swissmedic, 2026 -
Development of Antibody Conjugates as Specific and Potent Medicinal Products - a Regulator's Perspective
Speaker Presentation: CMC Strategy Forum Europe 2026 Gross Steffen, Paul-Ehrlich-Institut (PEI), … -
Maintenance of ICH Stability Guideline Series - Rapid Stability Prediction Based on Modeling
Speaker Presentation: CMC Strategy Forum Europe 2026 Gross Steffen, Paul-Ehrlich-Institut (PEI), … -
Welcome & Introduction to the EFPIA Manufacturing and Quality Expert Group (MQEG) - Biomanufacturing Satellite Session
Speaker Presentation: CMC Strategy Forum Europe 2026 Goese Markus, F. Hoffmann-La Roche Ltd., 2026 -
From Data to Decision: Leveraging Advanced Analytics for Enhanced Quality Control and Regulatory Compliance
Speaker Presentation: CMC Strategy Forum Europe 2026 Finkler Christof, F. Hoffmann-La Roche AG, 2026 -
Global Regulatory Frameworks for Conjugates: From EFPIA Smart Approaches to Regional Implementation
Speaker Presentation: CMC Strategy Forum Europe 2026 Duncan Katie, GlaxoSmithKline, Ruggiero Andrea, … -
Beyond One-Size-Fits-All: Experiences with Comparability Strategies for ADCs
Speaker Presentation: CMC Strategy Forum Europe 2026 Duncan Katie, GlaxoSmithKline, 2026 -
Agile (Innovative) Manufacturing and Decentralized Manufacturing in Latest Regulatory Environment Including New EU Pharma Legislation
Speaker Presentation: CMC Strategy Forum Europe 2026 Cox Colin, Pfizer, Inc., 2026 -
Stability Modeling for Biologicals and Vaccines
Speaker Presentation: CMC Strategy Forum Europe 2026 Clenet Didier, Sanofi, 2026 -
Practical Control of Polysorbate: Degradation Is Manageable
Speaker Presentation: CMC Strategy Forum Europe 2026 Chéry Cyrille, UCB Pharma SA, 2026 -
Regulatory Updates: EU Insights and Global Impact
Speaker Presentation: CMC Strategy Forum Europe 2026 Barry Seán, Health Products Regulatory Authority … -
CMC Strategy Forum Europe 2026 Scientific Program
Scientific Program: CMC Strategy Forum Europe 2026 -
CMC Strategy Forum Europe 2026 Summary Infographic
Summary Infographic: CMC Strategy Forum Europe 2026 -
Global Regulatory Strategy for Cell Therapy Development and Manufacturing
Speaker Presentation: Consultants' Network 2026 Xu Jingying, Kite Pharma, Inc., 2026